{"id":8345,"date":"2025-06-05T11:34:42","date_gmt":"2025-06-05T03:34:42","guid":{"rendered":"https:\/\/regask.com\/?p=8345"},"modified":"2025-07-17T10:53:12","modified_gmt":"2025-07-17T02:53:12","slug":"alimenter-des-essais-hybrides-mondiaux-simplifies-conformes-et-evolutifs","status":"publish","type":"post","link":"https:\/\/regask.com\/fr\/powering-global-hybrid-trials-simplified-compliant-and-scalable\/","title":{"rendered":"Alimenter les essais cliniques hybrides mondiaux\u00a0: simplification, com\u2026"},"content":{"rendered":"<h4><strong>Le d\u00e9fi<\/strong><\/h4>\n<p class=\"p1\">Une importante soci\u00e9t\u00e9 pharmaceutique mondiale se pr\u00e9parait \u00e0 d\u00e9ployer des essais cliniques hybrides pour son produit \u00ab\u00a0aliment destin\u00e9 \u00e0 des fins m\u00e9dicales sp\u00e9ciales\u00a0\u00bb. Cependant, la diversit\u00e9 et l&#039;\u00e9volution des r\u00e9glementations r\u00e9gionales ont constitu\u00e9 un obstacle majeur \u00e0 la mise en \u0153uvre efficace de ces essais.<\/p>\n<p class=\"p1\">Les cadres r\u00e9glementaires pour les essais cliniques hybrides et d\u00e9centralis\u00e9s (ECD) varient consid\u00e9rablement \u00e0 travers le monde, et il n\u2019existe pas de manuel harmonis\u00e9.<\/p>\n<p class=\"p1\">Les exigences en mati\u00e8re de consentement \u00e9lectronique, d&#039;outils de sant\u00e9 num\u00e9riques, de visites m\u00e9dicales \u00e0 domicile, de t\u00e9l\u00e9surveillance et de confidentialit\u00e9 des donn\u00e9es varient consid\u00e9rablement d&#039;une juridiction \u00e0 l&#039;autre. Le d\u00e9fi ne r\u00e9sidait pas seulement dans la mani\u00e8re de mener les essais, mais aussi dans la compr\u00e9hension des r\u00e9glementations applicables dans chaque pays, soulignant la n\u00e9cessit\u00e9 de guides r\u00e9glementaires adapt\u00e9s pour guider la mise en \u0153uvre locale.<\/p>\n<h4 data-start=\"781\" data-end=\"933\"><\/h4>\n<h4 data-start=\"781\" data-end=\"933\"><strong data-start=\"781\" data-end=\"804\">L&#039;approche RegASK<\/strong><\/h4>\n<p><span data-teams=\"true\">RegASK, en combinant ses <a href=\"https:\/\/regask.com\/fr\/produit\/#RegGenius:~:text=Book%20a%20demo-,RegGenius,-Your%20GenAI%20co\">Solution de renseignement r\u00e9glementaire bas\u00e9e sur l&#039;IA<\/a> avec sa profonde expertise du domaine, a apport\u00e9 une structure \u00e0 la complexit\u00e9.<\/span><\/p>\n<p>Nous avons livr\u00e9 un ensemble de <strong>Guides r\u00e9glementaires DCT<\/strong> pour 27 march\u00e9s strat\u00e9giques. Chaque guide comprenait\u00a0:<\/p>\n<ul>\n<li>Informations claires, valid\u00e9es et exploitables sur les r\u00e9glementations DCT locales<\/li>\n<li>Comparaisons nationales c\u00f4te \u00e0 c\u00f4te pour \u00e9valuer les exigences r\u00e9glementaires et l&#039;\u00e9tat de pr\u00e9paration<\/li>\n<li>Navigation pratique sous forme de questions-r\u00e9ponses pour soutenir les \u00e9quipes op\u00e9rationnelles cliniques et r\u00e9glementaires<\/li>\n<li>Mises \u00e0 jour continues pour maintenir les \u00e9quipes en phase avec l&#039;\u00e9volution des paysages r\u00e9glementaires<\/li>\n<\/ul>\n\t<div id=\"gap-69623557\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-69623557 {\n  padding-top: 30px;\n}\n<\/style>\n\t<\/div>\n\t\n<h4><strong>Points cl\u00e9s<\/strong><\/h4>\n\t<div id=\"gap-591459417\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-591459417 {\n  padding-top: 30px;\n}\n<\/style>\n\t<\/div>\n\t\n\t<div id=\"stack-3442128435\" class=\"stack stack-row justify-start items-stretch\">\n\t\t\n<div class=\"row equal-height-row\"  id=\"row-45964764\">\n\n\t<div id=\"col-1510188780\" class=\"col medium-4 small-12 large-4\"  >\n\t\t\t\t<div class=\"col-inner text-left dark\" style=\"background-color:rgb(10, 35, 66);\" >\n\t\t\t\n\t\t\t\n<h1>27<\/h1>\n<p>juridictions couvertes<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1510188780 > .col-inner {\n  padding: 10% 10% 10% 10%;\n  border-radius: 16px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-564249620\" class=\"col medium-4 small-12 large-4\"  >\n\t\t\t\t<div class=\"col-inner\" style=\"background-color:#e5e8fb;\" >\n\t\t\t\n\t\t\t\n<h1>90%<\/h1>\n<p>gain de temps pour compiler la r\u00e9glementation du pays<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-564249620 > .col-inner {\n  padding: 10% 10% 10% 10%;\n  border-radius: 16px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-732455117\" class=\"col medium-4 small-12 large-4\"  >\n\t\t\t\t<div class=\"col-inner dark\" style=\"background-color:#0a2342;\" >\n\t\t\t\n\t\t\t\n<h1>Facilit\u00e9<\/h1>\n<p>pour acc\u00e9der aux donn\u00e9es<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-732455117 > .col-inner {\n  padding: 10% 10% 10% 10%;\n  border-radius: 16px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n<style>\n#row-45964764 > .col > .col-inner {\n  background-color: #0a2342;\n  border-radius: 14px;\n}\n<\/style>\n<\/div>\n\t\t\n<style>\n#stack-3442128435 > * {\n  --stack-gap: 0rem;\n}\n<\/style>\n\t<\/div>\n\t\n<a href=\"https:\/\/regask.com\/fr\/contact-2\/\" class=\"button primary\" >\n\t\t<span>Apprenez-en plus sur l&#039;approche RegASK avec notre \u00e9quipe<\/span>\n\t<\/a>\n\n\t<div id=\"gap-1850868054\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1850868054 {\n  padding-top: 30px;\n}\n<\/style>\n\t<\/div>\n\t\n<h4><strong>Le r\u00e9sultat<\/strong><\/h4>\n<p>Le RegASK a permis une planification et une ex\u00e9cution des essais plus rapides et plus fiables en\u00a0:<\/p>\n<ul>\n<li>Prise de d\u00e9cision plus rapide et fond\u00e9e sur des donn\u00e9es probantes concernant la conception des essais et la strat\u00e9gie de lancement. \u00c9quipes cliniques et r\u00e9glementaires dot\u00e9es de renseignements localis\u00e9s et \u00e0 jour.<\/li>\n<li>\u00c9limination des recherches manuelles chronophages dans plusieurs pays<\/li>\n<li>Prise en charge du d\u00e9ploiement d&#039;essais cliniques hybrides conformes et \u00e9volutifs sur les march\u00e9s mondiaux<\/li>\n<\/ul>\n<p><strong>De l\u2019incertitude r\u00e9glementaire \u00e0 l\u2019avantage concurrentiel, RegASK a apport\u00e9 clart\u00e9, confiance et rapidit\u00e9.<\/strong><\/p>\n\t<div id=\"gap-650626230\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-650626230 {\n  padding-top: 30px;\n}\n<\/style>\n\t<\/div>\n\t\n<div class=\"is-divider divider clearfix\" style=\"max-width:100%;height:2px;background-color:rgb(197, 202, 236);\"><\/div>\n\t<div id=\"gap-217110196\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-217110196 {\n  padding-top: 30px;\n}\n<\/style>\n\t<\/div>\n\t\n<h2>Questions fr\u00e9quemment pos\u00e9es<\/h2>\n\t<div id=\"gap-1122731214\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1122731214 {\n  padding-top: 30px;\n}\n<\/style>\n\t<\/div>\n\t\n<h4><strong>Q1 : Comment le RegASK contribue-t-il \u00e0 simplifier la conformit\u00e9 DCT dans tous les pays ?<\/strong><\/h4>\n<p>RegASK simplifie la mise en \u0153uvre des essais cliniques en fournissant des informations claires et valid\u00e9es sur les exigences r\u00e9glementaires sp\u00e9cifiques \u00e0 chaque pays. Nos guides r\u00e9dig\u00e9s par des experts et notre plateforme de veille mondiale aident les parties prenantes \u00e0 comprendre les r\u00e9glementations locales relatives aux composants d\u00e9centralis\u00e9s tels que le consentement \u00e9lectronique, la t\u00e9l\u00e9m\u00e9decine et la surveillance \u00e0 distance, permettant ainsi des strat\u00e9gies d&#039;essai coh\u00e9rentes et conformes dans divers environnements r\u00e9glementaires.<\/p>\n<h4><\/h4>\n<h4><strong>Q2 : <span data-teams=\"true\">Quel contenu couvrent les guides r\u00e9glementaires ?<\/span><\/strong><\/h4>\n<p>Les guides r\u00e9glementaires du RegASK offrent un aper\u00e7u sp\u00e9cifique \u00e0 chaque pays du paysage des essais cliniques, couvrant le processus des comit\u00e9s d&#039;\u00e9thique, les d\u00e9lais et les \u00e9l\u00e9ments d\u00e9centralis\u00e9s tels que le consentement \u00e9lectronique, la signature \u00e9lectronique et le traitement des donn\u00e9es. Ils facilitent la planification et la gestion r\u00e9glementaire des essais sur les march\u00e9s cibles.<\/p>\n<h4><\/h4>\n<h4><strong>Q3 : Comment RegASK reste-t-il en avance sur les r\u00e9glementations en constante \u00e9volution ?<\/strong><\/h4>\n<p>RegASK reste en avance sur les r\u00e9glementations en constante \u00e9volution gr\u00e2ce \u00e0 une combinaison de :<\/p>\n<p>\u2022 outils de surveillance avanc\u00e9s bas\u00e9s sur l&#039;IA<br \/>\n\u2022 un r\u00e9seau mondial d&#039;experts en r\u00e9glementation<br \/>\n\u2022 analyse continue des mises \u00e0 jour officielles et des tendances du secteur<\/p>\n<p>Cela nous permet de fournir des informations valid\u00e9es en temps quasi r\u00e9el qui aident les clients \u00e0 s&#039;adapter rapidement et \u00e0 maintenir la conformit\u00e9 sur tous les march\u00e9s.<\/p>","protected":false},"excerpt":{"rendered":"<p>Le d\u00e9fi\u00a0: Une multinationale pharmaceutique de premier plan s\u2019appr\u00eatait \u00e0 d\u00e9ployer \u00e0 grande \u00e9chelle des essais cliniques hybrides pour son produit destin\u00e9 \u00e0 des fins m\u00e9dicales sp\u00e9ciales (FSMP). Cependant, la diversit\u00e9 et l\u2019\u00e9volution des r\u00e9glementations r\u00e9gionales constituaient un obstacle majeur \u00e0 la mise en \u0153uvre efficace de ces essais. Les cadres r\u00e9glementaires applicables aux essais cliniques hybrides et d\u00e9centralis\u00e9s (ECD) varient consid\u00e9rablement \u00e0 travers le monde, et aucun\u2026<\/p>","protected":false},"author":43,"featured_media":8358,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[17,527,18,21],"tags":[197],"class_list":["post-8345","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-case-study","category-united-states-regulations","category-food-and-beverage","category-pharma-and-biotech","tag-infant-formula"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.5 (Yoast SEO v28.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>US | Decentralized Clinical Trials for FSMP | Case Study | RegASK<\/title>\n<meta name=\"description\" content=\"Learn how RegASK enabled global hybrid clinical trials with tailored regulatory intelligence\u2014simplifying compliance and accelerating trial execution.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/fr\/alimenter-des-essais-hybrides-mondiaux-simplifies-conformes-et-evolutifs\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Powering Global Hybrid Clinical Trials: Simplified, Compliant, and Scalable\" \/>\n<meta property=\"og:description\" content=\"Learn how RegASK enabled global hybrid clinical trials with tailored regulatory intelligence\u2014simplifying compliance and accelerating trial execution.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/fr\/alimenter-des-essais-hybrides-mondiaux-simplifies-conformes-et-evolutifs\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-05T03:34:42+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-17T02:53:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/06\/global-hybrid-trials-simplified-compliant-scalable-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Reva Ananda\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Reva Ananda\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/powering-global-hybrid-trials-simplified-compliant-and-scalable\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/powering-global-hybrid-trials-simplified-compliant-and-scalable\\\/\"},\"author\":{\"name\":\"Reva Ananda\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/4023a3aab44f61a84d06ca8abfcbe926\"},\"headline\":\"Powering Global Hybrid Clinical Trials: Simplified, Com&hellip;\",\"datePublished\":\"2025-06-05T03:34:42+00:00\",\"dateModified\":\"2025-07-17T02:53:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/powering-global-hybrid-trials-simplified-compliant-and-scalable\\\/\"},\"wordCount\":511,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/powering-global-hybrid-trials-simplified-compliant-and-scalable\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/global-hybrid-trials-simplified-compliant-scalable-1.png\",\"keywords\":[\"Infant Formula\"],\"articleSection\":[\"Case Studies\",\"United States\",\"Food and Nutrition\",\"Pharma and Biotech\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/powering-global-hybrid-trials-simplified-compliant-and-scalable\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/powering-global-hybrid-trials-simplified-compliant-and-scalable\\\/\",\"name\":\"US | Decentralized Clinical Trials for FSMP | Case Study | RegASK\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/powering-global-hybrid-trials-simplified-compliant-and-scalable\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/powering-global-hybrid-trials-simplified-compliant-and-scalable\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/global-hybrid-trials-simplified-compliant-scalable-1.png\",\"datePublished\":\"2025-06-05T03:34:42+00:00\",\"dateModified\":\"2025-07-17T02:53:12+00:00\",\"description\":\"Learn how RegASK enabled global hybrid clinical trials with tailored regulatory intelligence\u2014simplifying compliance and accelerating trial execution.\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/powering-global-hybrid-trials-simplified-compliant-and-scalable\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/regask.com\\\/powering-global-hybrid-trials-simplified-compliant-and-scalable\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/global-hybrid-trials-simplified-compliant-scalable-1.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/global-hybrid-trials-simplified-compliant-scalable-1.png\",\"width\":800,\"height\":600,\"caption\":\"Global Hybrid Trials Simplified Compliant Scalable 1\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\",\"name\":\"RegASK\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"width\":401,\"height\":401,\"caption\":\"RegASK\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RegASKRegulatoryAffairs\\\/\",\"https:\\\/\\\/x.com\\\/ASKRegASK\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/RegASK\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@RegASK\",\"https:\\\/\\\/www.crunchbase.com\\\/organization\\\/regask\",\"https:\\\/\\\/www.bloomberg.com\\\/profile\\\/company\\\/1691237D:SP\",\"https:\\\/\\\/pitchbook.com\\\/profiles\\\/company\\\/265004-02\",\"https:\\\/\\\/www.cbinsights.com\\\/company\\\/RegASK\",\"https:\\\/\\\/vimeo.com\\\/RegASK\"],\"legalName\":\"RegASK PTE. LTD.\",\"foundingDate\":\"2018\",\"slogan\":\"Empowering Smarter Regulatory Decisions\",\"description\":\"Agentic AI regulatory intelligence and workflow orchestration platform for Life Sciences and Consumer Products. RegASK combines vertical LLMs, multi-agent AI architecture, and a global community of 1,800+ subject matter experts to deliver regulatory horizon scanning, impact analysis, compliance workflow automation, and audit-ready outputs across 160+ countries.\",\"areaServed\":\"Worldwide\",\"founder\":{\"@type\":\"Person\",\"name\":\"Caroline Shleifer\",\"jobTitle\":\"Founder & CEO\"},\"address\":{\"@type\":\"PostalAddress\",\"streetAddress\":\"79 Science Park Drive, #06-01, Cintech IV\",\"addressLocality\":\"Singapore\",\"postalCode\":\"118264\",\"addressCountry\":\"SG\"},\"contactPoint\":{\"@type\":\"ContactPoint\",\"telephone\":\"+65 6817 6290\",\"contactType\":\"customer service\",\"availableLanguage\":[\"English\",\"French\",\"Japanese\",\"Spanish\",\"Chinese\",\"German\"]},\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":50,\"maxValue\":100},\"knowsAbout\":[\"Regulatory Intelligence\",\"Regulatory Compliance\",\"Regulatory Affairs\",\"Workflow Orchestration\",\"Life Sciences Regulation\",\"Consumer Products Regulation\",\"AI-Driven Compliance\"],\"hasCertification\":[{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 42001:2023\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27001:2022\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27701\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27018:2019\"},{\"@type\":\"Certification\",\"name\":\"SOC 2 Type II\"}]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/4023a3aab44f61a84d06ca8abfcbe926\",\"name\":\"Reva Ananda\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"\u00c9tats-Unis | Essais cliniques d\u00e9centralis\u00e9s pour le FSMP | \u00c9tude de cas | RegASK","description":"D\u00e9couvrez comment RegASK a permis des essais cliniques hybrides mondiaux avec des renseignements r\u00e9glementaires sur mesure, simplifiant ainsi la conformit\u00e9 et acc\u00e9l\u00e9rant l&#039;ex\u00e9cution des essais.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/fr\/alimenter-des-essais-hybrides-mondiaux-simplifies-conformes-et-evolutifs\/","og_locale":"fr_FR","og_type":"article","og_title":"Powering Global Hybrid Clinical Trials: Simplified, Compliant, and Scalable","og_description":"Learn how RegASK enabled global hybrid clinical trials with tailored regulatory intelligence\u2014simplifying compliance and accelerating trial execution.","og_url":"https:\/\/regask.com\/fr\/alimenter-des-essais-hybrides-mondiaux-simplifies-conformes-et-evolutifs\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2025-06-05T03:34:42+00:00","article_modified_time":"2025-07-17T02:53:12+00:00","og_image":[{"width":800,"height":600,"url":"https:\/\/regask.com\/wp-content\/uploads\/2025\/06\/global-hybrid-trials-simplified-compliant-scalable-1.png","type":"image\/png"}],"author":"Reva Ananda","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Reva Ananda","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/powering-global-hybrid-trials-simplified-compliant-and-scalable\/#article","isPartOf":{"@id":"https:\/\/regask.com\/powering-global-hybrid-trials-simplified-compliant-and-scalable\/"},"author":{"name":"Reva Ananda","@id":"https:\/\/regask.com\/#\/schema\/person\/4023a3aab44f61a84d06ca8abfcbe926"},"headline":"Powering Global Hybrid Clinical Trials: Simplified, Com&hellip;","datePublished":"2025-06-05T03:34:42+00:00","dateModified":"2025-07-17T02:53:12+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/powering-global-hybrid-trials-simplified-compliant-and-scalable\/"},"wordCount":511,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/powering-global-hybrid-trials-simplified-compliant-and-scalable\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/06\/global-hybrid-trials-simplified-compliant-scalable-1.png","keywords":["Infant Formula"],"articleSection":["Case Studies","United States","Food and Nutrition","Pharma and Biotech"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/regask.com\/powering-global-hybrid-trials-simplified-compliant-and-scalable\/","url":"https:\/\/regask.com\/powering-global-hybrid-trials-simplified-compliant-and-scalable\/","name":"\u00c9tats-Unis | Essais cliniques d\u00e9centralis\u00e9s pour le FSMP | \u00c9tude de cas | RegASK","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/powering-global-hybrid-trials-simplified-compliant-and-scalable\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/powering-global-hybrid-trials-simplified-compliant-and-scalable\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/06\/global-hybrid-trials-simplified-compliant-scalable-1.png","datePublished":"2025-06-05T03:34:42+00:00","dateModified":"2025-07-17T02:53:12+00:00","description":"D\u00e9couvrez comment RegASK a permis des essais cliniques hybrides mondiaux avec des renseignements r\u00e9glementaires sur mesure, simplifiant ainsi la conformit\u00e9 et acc\u00e9l\u00e9rant l&#039;ex\u00e9cution des essais.","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/powering-global-hybrid-trials-simplified-compliant-and-scalable\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/regask.com\/powering-global-hybrid-trials-simplified-compliant-and-scalable\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2025\/06\/global-hybrid-trials-simplified-compliant-scalable-1.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/06\/global-hybrid-trials-simplified-compliant-scalable-1.png","width":800,"height":600,"caption":"Global Hybrid Trials Simplified Compliant Scalable 1"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Le syst\u00e8me d&#039;exploitation d&#039;IA r\u00e9glementaire pour les \u00e9quipes performantes","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/regask.com\/#organization","name":"RegASK","url":"https:\/\/regask.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","width":401,"height":401,"caption":"RegASK"},"image":{"@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","https:\/\/x.com\/ASKRegASK","https:\/\/www.linkedin.com\/company\/RegASK\/","https:\/\/www.youtube.com\/@RegASK","https:\/\/www.crunchbase.com\/organization\/regask","https:\/\/www.bloomberg.com\/profile\/company\/1691237D:SP","https:\/\/pitchbook.com\/profiles\/company\/265004-02","https:\/\/www.cbinsights.com\/company\/RegASK","https:\/\/vimeo.com\/RegASK"],"legalName":"RegASK PTE. LTD.","foundingDate":"2018","slogan":"Empowering Smarter Regulatory Decisions","description":"Plateforme d&#039;intelligence artificielle multi-agents pour la veille r\u00e9glementaire et l&#039;orchestration des flux de travail dans le secteur des sciences de la vie et des produits de consommation. RegASK combine des LLM verticaux, une architecture d&#039;IA multi-agents et une communaut\u00e9 mondiale de plus de 1\u00a0800 experts pour fournir une veille r\u00e9glementaire, une analyse d&#039;impact, l&#039;automatisation des processus de conformit\u00e9 et des r\u00e9sultats pr\u00eats pour l&#039;audit dans plus de 160 pays.","areaServed":"Worldwide","founder":{"@type":"Person","name":"Caroline Shleifer","jobTitle":"Founder & CEO"},"address":{"@type":"PostalAddress","streetAddress":"79 Science Park Drive, #06-01, Cintech IV","addressLocality":"Singapore","postalCode":"118264","addressCountry":"SG"},"contactPoint":{"@type":"ContactPoint","telephone":"+65 6817 6290","contactType":"customer service","availableLanguage":["English","French","Japanese","Spanish","Chinese","German"]},"numberOfEmployees":{"@type":"QuantitativeValue","minValue":50,"maxValue":100},"knowsAbout":["Regulatory Intelligence","Regulatory Compliance","Regulatory Affairs","Workflow Orchestration","Life Sciences Regulation","Consumer Products Regulation","AI-Driven Compliance"],"hasCertification":[{"@type":"Certification","name":"ISO\/IEC 42001:2023"},{"@type":"Certification","name":"ISO\/IEC 27001:2022"},{"@type":"Certification","name":"ISO\/IEC 27701"},{"@type":"Certification","name":"ISO\/IEC 27018:2019"},{"@type":"Certification","name":"SOC 2 Type II"}]},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/4023a3aab44f61a84d06ca8abfcbe926","name":"Reva Ananda"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts\/8345","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/users\/43"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/comments?post=8345"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts\/8345\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/media\/8358"}],"wp:attachment":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/media?parent=8345"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/categories?post=8345"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/tags?post=8345"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}